Therefore, it is reasonable to speculate that therapeutic approaches (i.e., weight loss, regular physical exercise, and the potential development of pharmacological interventions) which elevate circulating PTX3 concentrations in obese individuals will help restore obesity-related inflammatory imbalances and shift the systemic and local inflammatory microenvironments to an anti-inflammatory milieu. Here, PTX3 is linked to obesity disorder.